To ask the Secretary of State for Health and Social Care, what progress he has made on the research study into the long-term health effects of covid-19 on hospitalised patients announced on 5 July 2020.
This answer is the replacement for a previous holding answer.
15 September 2020
The National Institute for Health Research and UK Research and Innovation have invested £8.4 million in the Post-HOSPitalisation COVID-19 study (PHOSP-COVID), led by the University of Leicester. The study is one of the world’s largest comprehensive research studies into the long-term health impacts of COVID-19 on hospitalised patients.
The study is well underway and has established a national platform to integrate research and clinical service. The first patient was recruited on 10 August. The study has received approval from the Research Ethics Committee and obtained ISRCTN registration. Further information is available at the following link:
The researchers have also established nine expert working groups and a Patient, Public Involvement Group to ensure the value of the patient voice is maximised and integrated in PHOSP-COVID.